Calcium metabolism in the early posttransplantation period

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue 3, 2009, Pages 665-672

  Evenepoel, Pieter ^a   Van Den Bergh, Barbara ^a   Naesens, Maarten ^a   De Jonge, Hylke ^a   Bammens, Bert ^a   Claes, Kathleen ^a   Kuypers, Dirk ^a   Vanrenterghem, Yves ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIFEDIOL; CALCITRIOL; CALCIUM; PARATHYROID HORMONE; PHOSPHORUS; BIOLOGICAL MARKER;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM METABOLISM; CALCIUM TRANSPORT; CALCIUM URINE LEVEL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; GLOMERULONEPHRITIS; HEMODIALYSIS; HUMAN; HYPERCALCEMIA; HYPOCALCEMIA; INTERSTITIAL NEPHRITIS; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PARATHYROID HORMONE BLOOD LEVEL; PERITONEAL DIALYSIS; PHOSPHATE BLOOD LEVEL; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; AGED; BLOOD; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; PREDICTION AND FORECASTING; TIME; TREATMENT OUTCOME; URINE;

ADULT; AGED; BIOLOGICAL MARKERS; CALCIFEDIOL; CALCITRIOL; CALCIUM; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERCALCEMIA; HYPOCALCEMIA; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHORUS; POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 66149129209     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03920808     Document Type: Article

References (40)

1. Evenepoel P, Claes K, Kuypers D, Maes B, Bammens B, Vanrenterghem Y: Natural history of parathyroid function and calcium metabolism after kidney transplantation: A single-centre study. Nephrol Dial Transplant 19: 1281-1287, 2004 (Pubitemid 38628152)
2. Cundy T, Kanis JA, Heynen G, Morris PJ, Oliver DO: Calcium metabolism and hyperparathyroidism after renal transplantation. QJM 52: 67-78, 1983 (Pubitemid 14248199)
3. Ramezani M, Einollahi B, Asl MA, Nafar M, Pourfarziani V, Moradi M, Samadpour A, Alghasi M, Davoudi F: Calcium and phosphorus metabolism disturbances after renal transplantation. Transplant Proc 39: 1033-1035, 2007 (Pubitemid 46764868)
4. Stavroulopoulos A, Cassidy MJ, Porter CJ, Hosking DJ, Roe SD: Vitamin D status in renal transplant recipients. Am J Transplant 7: 2546-2552, 2007 (Pubitemid 47561620)
5. Reinhardt W, Bartelworth H, Jockenhövel F, Schmidt-Gayk H, Witzke O, Wagner K, Heemann UW, Reinwein D, Philipp T, Mann K: Sequential changes of biochemical bone parameters after kidney transplantation. Nephrol Dial Transplant 13: 436-442, 1998 (Pubitemid 28062209)
6. Bonarek H, Merville P, Bonarek M, Moreau K, Morel D, Aparicio M, Potaux L: Reduced parathyroid functional mass after successful kidney transplantation. Kidney Int 56: 642-649, 1999
7. Schwartz GH, David DS, Riggio RR, Saville PD, Whitsell JC, Stenzel KH, Rubin AL: Hypercalcemia after renal transplantation. Am J Med 49: 42-51, 1970
8. National Kidney Foundation: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42: S1-S201, 2003
9. Bouillon R, De Moor P, Baggiolini EG, Uskokovic MR: A radioimmunoassay for 1,25-dihydroxycholecalciferol. Clin Chem 26: 562-567, 1980
10. Bouillon R, Van Herck E, Jans I, Tan BK, Van Baelen H, De Moor P: Two direct (nonchromatographic) assays for 25-hydroxyvitamin D. Clin Chem 30: 1731-1736, 1984 (Pubitemid 15116038)
11. Bouillon R, Coopmans W, Degroote DE, Radoux D, Eliard PH: Immunoradiometric assay of parathyrin with polyclonal and monoclonal region-specific antibodies. Clin Chem 36: 271-276, 1990 (Pubitemid 20083866)
12. Souberbielle JC, Boutten A, Carlier MC, Chevenne D, Coumaros G, Lawson-Body E, Massart C, Monge M, Myara J, Parent X, Plouvier E, Houillier P: Inter-method variability in PTH measurement: Implication for the care of CKD patients. Kidney Int 70: 345-350, 2006 (Pubitemid 44086584)
13. Rotschild M, Schreiber S, Oratz M, McGee H: The effects of adrenocortical hormones on albumin metabolism studied by albumin-I131. J Clin Invest 37: 1229-1235, 1958
14. Haris A, Sherrard DJ, Hercz G: Reversal of adynamic bone disease by lowering of dialysate calcium. Kidney Int 70: 931-937, 2006 (Pubitemid 44285971)
15. Elming H, Holm E, Jun L, Torp-Pedersen C, Kober L, Kircshoff M, Malik M, Camm J: The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens. Eur Heart J 19: 1391-1400, 1998 (Pubitemid 28427142)
16. Iwazu Y, Muto S, Ikeuchi S, Yanagiba S, Miyata Y, Asano Y, Kusano E: Reversible hypocalcemic heart failure with T wave alternans and increased QTc dispersion in a patient with chronic renal failure after parathyroidectomy. Clin Nephrol 65: 65-70, 2006 (Pubitemid 43091699)
17. Nappi SE, Virtanen VK, Saha HH, Mustonen JT, Pasternack AI: QTc dispersion increases during hemodialysis with low-calcium dialysate. Kidney Int 57: 2117-2122, 2000
18. David DS, Sakal S, Brennan L, Riggio RA, Cheigh J, Stenzel KH, Rubin AL, Sherwood LM: Hypercalcemia after renal transplantation: Long-term follow-up data. N Engl J Med 289: 398-401, 1973
19. Parfitt A: Hypercalcemic hyperparathyroidism following renal transplantation: Differential diagnosis, management, and implications for cell population control in the parathyroid gland. Miner Electrolyte Metab 8: 92-112, 1982
20. Lambers TT, Bindels RJM, Hoenderop JG: Coordinated control of renal Ca2+ handling. Kidney Int 69: 650-654, 2006 (Pubitemid 43237632)
21. Dusso AS, Brown AJ, Slatopolsky E: Vitamin D. Am J Physiol Renal Physiol 289: F8-F28, 2005
22. Coburn JW, Koppel MH, Brickman AS, Massry SG: Study of intestinal absorption of calcium in patients with renal failure. Kidney Int 3: 264-272, 1973
23. Teitelbaum SL: Bone resorption by osteoclasts. Science 289: 1504-1508, 2000
24. Kurz P, Monier-Faugere M-C, Bognar B, Werner E, Roth P, Valchojannis J, Malluche HH: Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int 46: 855-861, 1994 (Pubitemid 24272045)
25. Nabeshima Yi: The discovery of alpha-Klotho and FGF23 unveiled new insight into calcium and phosphate homeostasis. Cell Mol Life Sci 65: 3218-3230, 2008
26. Özdemir FN, Afsar B, Akgul A, Usluogullari C, Akçay A, Haberal M: Persistent hypercalcemia is a significant risk factor for graft dysfunction in renal transplantation recipients. Transplant Proc 38: 480-482, 2006
27. Gwinner W, Suppa S, Mengel M, Hoy L, Kreipe HH, Haller H, Schwarz A: Early calcification of renal allografts detected by protocol biopsies: Causes and clinical implications. Am J Transplant 5: 1934-1941, 2005
28. Reynolds JL, Joannides AJ, Skepper JN, McNair R, Schurgers LJ, Proudfoot D, Jahnen-Dechent W, Weissberg PL, Shanahan CM: Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: A potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 15: 2857-2867, 2004 (Pubitemid 41103395)
29. Evenepoel P, Claes K, Kuypers DR, Debruyne F, Vanrenterghem Y: Parathyroidectomy after successful kidney transplantation: A single centre study. Nephrol Dial Transplant 22: 1730-1737, 2007 (Pubitemid 47073776)
30. Triponez H, Clark OH, Vanrenterghem Y, Evenepoel P: Surgical treatment of persistent hyperparathyroidism after transplantation. Ann Surg 248: 18-30, 2008
31. Serra AL, Savoca R, Huber AR, Hepp U, Delsignore A, Hersberger M, Wuthrich RP: Effective control of persistent hyperparathyroidism with cinacalcet in renal allograft recipients. Nephrol Dial Transplant 22: 577-583, 2007 (Pubitemid 46189904)
32. Kruse AE, Eisenberger U, Frey FJ, Mohaupt MG: Effect of cinacalcet cessation in renal transplant recipients with persistent hyperparathyroidism. Nephrol Dial Transplant 22: 2362-2365, 2007 (Pubitemid 47244719)
33. Srinivas TR, Schold JD, Womer KL, Kaplan B, Howard RJ, Bucci CM, Meier-Kriesche HU: Improvement in hypercalcemia with cinacalcet after kidney transplantation. Clin J Am Soc Nephrol 1: 323-326, 2006
34. Leca N, Laftavi M, Gundroo A, Kohli R, Min I, Karam J, Sridhar N, Blessios G, Venuto R, Pankewycz O: Early and severe hyperparathyroidism associated with hypercalcemia after renal transplant treated with cinacalcet. Am J Transplant 6: 2391-2395, 2006 (Pubitemid 44359425)
35. El-Amm JM, Doshi MD, Singh A, Migdal S, Morawski K, Sternbauer D, Cincotta E, West MS, Losanoff JE, Gruber SA: Preliminary experience with cinacalcet use in persistent secondary hyperparathyroidism after kidney transplantation. Transplantation 83: 546-549, 2007 (Pubitemid 46440240)
36. Szwarc I, Argiles A, Garrique V, Delmas S, Chong G, Deleuze S, Mourad G: Cinacalcet chloride is efficient and safe in renal transplant recipients with posttransplant hyperparathyroidism. Transplantation 82: 675-680, 2006 (Pubitemid 44395239)
37. Bergua C, Torregrosa J-V, Cofan F, Oppenheimer F: Cinacalcet for the treatment of hypercalcemia in renal transplanted patients with secondary hyperparathyroidism. Transplant Proc 39: 2254-2255, 2007 (Pubitemid 47418225)
38. Wissing KM, Broeders N, Moreno-Reyers R, Gervy C, Stallenberg B, Abramowicz D: A controlled study of vitamin D3 to prevent bone loss in renal-transplant patients receiving low doses of steroids. Transplantation 79: 108-115, 2005 (Pubitemid 40140008)
39. Steiner RW, Ziegler M, Halasz NA, Catherwood BD, Manolagas S, Deftos LJ: Effect of daily oral vitamin D and calcium therapy, hypophosphatemia, and endogenous 1-25 dihydroxycholecalciferol on parathyroid hormone and phosphate wasting in renal transplant recipients. Transplantation 56: 843-846, 1993 (Pubitemid 23321515)
40. Evenepoel P, Naesens M, Claes K, Kuypers D, Vanrenterghem Y: Tertiary 'hyperphosphatoninism' accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients. Am J Transplant 7: 1193-1200, 2007 (Pubitemid 46643105)